Status:
WITHDRAWN
EBUS-TBNA Versus EBUS-TBNB
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
Chelsea and Westminster NHS Foundation Trust
Heidelberg University
Conditions:
Mediastinal Lymphadenopathy
Hilar Lymphadenopathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective diagnostic clinical study randomising patients undergoing endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) of enlarged mediastinal and hilar lymph nodes to ha...
Eligibility Criteria
Inclusion
- Scheduled for EBUS-TBNA as part of clinical care
- Lymph nodes larger than 10mm in diameter
- Age \> 18 years
- Able to provide written informed consent
Exclusion
- Contraindications for needle or forceps biopsy (e.g. coagulopathy, anticoagulation, thrombocytopenia)
- Inability to obtain informed consent
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01467635
Start Date
May 1 2014
End Date
July 1 2016
Last Update
July 13 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoraxklinik, University of Heidelberg
Heidelberg, Germany, D-69126
2
Chelsea and Westminster Hospital
London, United Kingdom, SW10 9NH
3
The Royal Brompton Hospital
London, United Kingdom, SW3 6NP